| 000 | 01368 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516200646.0 | ||
| 264 | 0 | _c20141007 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2014.86 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStübig, T | |
| 245 | 0 | 0 |
_aJAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis. _h[electronic resource] |
| 260 |
_bLeukemia _cAug 2014 |
||
| 300 |
_a1736-8 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJanus Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 |
_aPrimary Myelofibrosis _xdrug therapy |
| 650 | 0 | 4 |
_aPyrazoles _xadverse effects |
| 650 | 0 | 4 | _aPyrimidines |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 700 | 1 | _aAlchalby, H | |
| 700 | 1 | _aDitschkowski, M | |
| 700 | 1 | _aWolf, D | |
| 700 | 1 | _aWulf, G | |
| 700 | 1 | _aZabelina, T | |
| 700 | 1 | _aWolschke, C | |
| 700 | 1 | _aAyuk, F | |
| 700 | 1 | _aKröger, N | |
| 773 | 0 |
_tLeukemia _gvol. 28 _gno. 8 _gp. 1736-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2014.86 _zAvailable from publisher's website |
| 999 |
_c23586016 _d23586016 |
||